JFLB(002762)

Search documents
金发拉比:关于按期收回现金管理产品本金及收益的公告
2024-05-31 08:47
金发拉比妇婴童用品股份有限公司 关于按期收回现金管理产品本金及收益的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假记载、误导 性陈述或重大遗漏。 金发拉比妇婴童用品股份有限公司(以下简称"公司")第四届董事会第三次会议审议 通过了《关于调整闲置自有资金现金管理额度的议案》,同意公司使用自有资金总额不超过 45,000 万元进行现金管理,购买商业银行等金融机构发行的安全性高、流动性好、有合适收 益的现金管理产品,自有资金在上述额度内可循环使用。现将公司购买的已到期现金管理产品 及收益情况公告如下: 1 证券代码:002762 证券简称:金发拉比 公告编号:2024-023号 目前公司购买的上述现金管理产品已到期,截至本公告发出日,上述现金管理产品本金 22,000 万元及收益 1,105,179.72 元已收回至本公司账户。 特此公告 金发拉比妇婴童用品股份有限公司董事会 2024 年 6 月 1 日 | 产品名称 | 产品 | 资金 | 收益起 | | | | 产品到 | | | | | 投资 | | 赎回本金 | 收益金额 | 预期年化收 | | | | | --- | --- | ...
金发拉比:2023年度权益分派实施公告
2024-05-15 11:47
证券代码:002762 证券简称:金发拉比 公告编号: 2024-022 号 金发拉比妇婴童用品股份有限公司 2023 年度权益分派实施公告 本公司及董事会全体成员保证公告内容真实、准确和完整,不存在虚假记载、误导性陈述 或者重大遗漏。 重要内容提示: 一、股东大会审议通过利润分配及资本公积金转增股本的情况 1、权益分派方案的具体内容:以公司总股本 354,025,000 股为基数,向全体股东每 10 股派发现金红利 0.5 元(含税),本次利润分配共 17,701,250.00 元,不以资本公积金转增股 本,不送红股。本次实施的权益分派方案以固定总额的方式分配,并已获 2024 年 5 月 8 日召开 的 2023 年年度股东大会审议通过。 2、自上述利润分配方案披露至实施期间,公司总股本未发生变化。 3、本次实施的利润分配方案与公司 2023 年年度股东大会审议通过的分配方案一致。 4、本次实施利润分配方案距离股东大会审议通过之日未超过两个月。 本次权益分派股权登记日为:2024 年 5 月 22 日(星期三); 二、权益分派方案 本公司 2023 年年度权益分派方案为:以公司现有总股本 354,025, ...
金发拉比:2023年年度股东大会决议的公告
2024-05-08 10:49
证券简称:金发拉比 证券代码:002762 公告编号:2024-021 号 金发拉比妇婴童用品股份有限公司 2023 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 金发拉比妇婴童用品股份有限公司(以下简称"公司")《关于召开 2023 年 年度股东大会的通知》于 2024 年 4 月 18 日在《中国证券报》、《证券时报》、《上 海证券报》及巨潮资讯网站上公告,本次会议如期举行。 特别提示: 1、本次年度股东大会采取现场投票与网络投票相结合的方式。 2、本次年度股东大会无新增、变更、否决提案的情况。 3、本次年度股东大会不涉及变更以往股东大会已通过的决议。 4、为尊重中小投资者利益,提高中小投资者对公司股东大会决议重大事项 的参与度,本次股东大会审议的相关议案对中小投资者单独计票。中小投资者是 指"除公司董事、监事、高级管理人员以及单独或者合计持有公司 5%以上股份 的股东以外的其他股东"。 一、会议召开情况 1、会议召开时间 (1)现场会议时间:2024年5月8日(星期三)下午14:30 (2)网络投票时间: 深交所交易系统:202 ...
金发拉比:北京市中伦(广州)律师事务所关于金发拉比2023年度股东大会的法律意见书
2024-05-08 10:49
北京市中伦(广州)律师事务所 关于金发拉比妇婴童用品股份有限公司 2023 年年度股东大会的法律意见书 致:金发拉比妇婴童用品股份有限公司 北京市中伦(广州)律师事务所(以下简称"本所")受金发拉比妇婴童用 品股份有限公司(以下简称"公司")委托,指派本所律师陈竞蓬、刘杰(以下 简称"本所律师")出席公司 2023 年年度股东大会(以下简称"本次股东大 会")。本所律师根据《中华人民共和国公司法》(以下简称"《公司法》")、 《上市公司股东大会规则》等有关法律、法规、规范性文件及《金发拉比妇婴童 用品股份有限公司章程》(以下简称"《公司章程》")的规定,对公司本次股 东大会进行见证并出具法律意见。 为出具本法律意见书,本所律师审查了公司本次股东大会的有关文件和材料。 本所律师得到公司如下保证,即其已提供了本所律师认为作为出具本法律意见书 所必需的材料,所提供的原始材料、副本、复印件等材料、口头证言均符合真实、 准确、完整的要求,有关副本、复印件等材料与原始材料一致。 在本法律意见书中,本所律师仅对本次股东大会的召集、召开程序、出席本 次股东大会人员和召集人的资格、会议表决程序及表决结果是否符合《公司法》 《上 ...
金发拉比:金发拉比2023年度业绩说明会
2024-04-30 08:56
证券代码:002762 证券简称:金发拉比 编号:20240430 投资者关系活动类别 □特定对象调研 □分析师会议 □媒体采访 √业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 (请文字说明其他活动内容) 参与单位名称及人员姓名 投资者 时间 2024 年 4 月 30 日 地点 全景网路演系统 上市公司接待人员姓名 董事长:林浩亮先生;副董事长:汤典勤先生;董事、 总经理:林国栋先生;独立董事:姚明安先生、纪传盛 先生、蔡飙先生;董事会秘书:薛平安先生;财务总监: 林贵贤先生。 投资者关系活动主要内容介绍 问题 1:公司在一线城市的布局也很有限,在北京也就 在通州有几家门店,未来如何考虑。 回复:尊敬的投资者,您好!公司目前在北京市东城区、 海淀区、昌平区、丰台区、石景山区等主要行政区域都 开设有拉比品牌门店。一线城市北京、上海、广州、深 圳及新一线城市重庆、杭州、西安、武汉、苏州、长沙、 东莞、佛山、合肥、青岛、宁波等均有公司的品牌专卖 店。 公司线上销售渠道包括主流电商平台、直营微商 城、抖音直播店等。公司搭建中后台系统链接线上线下, 通过直播带货、社群营销等赋能线下实体门店,并通过 微商城 ...
金发拉比:关于获得2023年度广东省工程技术研究中心认定的公告
2024-04-24 08:28
证券代码:002762 证券简称:金发拉比 公告编号:2024-020号 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 金发拉比妇婴童用品股份有限公司 特此公告 关于获得"2023 年度广东省工程技术研究中心"认定 的公告 金发拉比妇婴童用品股份有限公司董事会 2024 年 4 月 25 日 广东省科学技术厅于 2024 年 4 月 23 日发布了《关于认定 2023 年度广东省 工程技术研究中心的通知》(粤科函产字〔2024〕346 号)。经专家评审和网上公 示,认定金发拉比妇婴童用品股份有限公司(以下简称"公司")申报的"广东 省安全健康妇婴童用品工程技术研究中心"为"2023 年度广东省工程技术研究 中心"。 据公开资料显示,该中心是构建以企业为主体、市场为导向、产学研用深度 融合的技术创新体系的重要科研平台。公司将积极探索专业化的母婴产品科研项 目,推动成果转化,充分利用好政府的配套支持政策,提高本中心的自主创新能 力和研发水平,营造企业创新发展的良好环境。 本次公司被认定为 2023 年度广东省工程技术研究中心,是公司多年来重视 新技术研发、坚持工 ...
金发拉比:关于提请股东大会授权董事会办理小额快速融资相关事宜的公告
2024-04-18 12:02
金发拉比妇婴童用品股份有限公司 关于提请股东大会授权董事会办理小额快速融资 相关事宜的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或者重大遗漏。 金发拉比妇婴童用品股份有限公司(以下简称"公司")于 2024 年 4 月 16 日召开第五届董事会第八次会议,会议审议通过了《关于提请股东大会授权董事 会办理小额快速融资相关事宜的议案》。本议案尚需提交公司 2023 年度股东大 会审议。现将相关事项公告如下: 证券代码:002762 证券简称:金发拉比 公告编号:2024-016号 根据《上市公司证券发行注册管理办法》《深圳证券交易所上市公司证券发 行上市审核规则》《深圳证券交易所上市公司证券发行与承销业务实施细则》等 相关规定,公司董事会提请股东大会授权董事会决定向特定对象发行融资总额不 超过人民币 3 亿元且不超过最近一年末净资产 20%的股票,授权期限为自 2023 年年度股东大会通过之日起至 2024 年年度股东大会召开之日止。本次授权事宜 包括以下内容: 1、确认公司是否符合以简易程序向特定对象发行股票(以下简称"小额快 速融资")的条件 授权董事会根据《中 ...
金发拉比:关于举办2023年度网上业绩说明会的公告
2024-04-17 13:24
本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏。 金发拉比妇婴童用品股份有限公司(以下简称"公司")《2023 年年度报告及摘 要》经公司第五届董事会第八次会议审议通过,已于 2024 年 4 月 18 日在《中国证券 报》、《证券时报》、《上海证券报》和巨潮资讯网(www.cninfo.com.cn)等法定信 批媒体披露。 为便于广大投资者进一步了解公司《2023 年年度报告》和公司生产经营情况,公 司将于 2024 年 4 月 30 日(星期二)下午 15:00 至 16:00 在全景网提供的网上平台举 办 2023 年度网上业绩说明会。 本次网上业绩说明会将采用网络远程方式举行,投资者可登陆投资者互动平台 "全景·路演 (http://rs.p5w.net)"参与本次网上业绩说明会。 现场出席本次网上业绩说明会的人员有:林浩亮(董事长)、汤典勤(副董事长)、 林国栋(总经理)、蔡飙(独立董事)、姚明安(独立董事)、纪传盛(独立董事)、林 贵贤(财务总监)、薛平安(董事会秘书)。 欢迎广大投资者积极参与! 证券代码:002762 证券简称:金发拉比 公告编 ...
金发拉比(002762) - 2023 Q4 - 年度财报
2024-04-17 13:24
Financial Performance - The company's operating revenue for 2023 was ¥204,174,512.52, a decrease of 16.79% compared to ¥245,364,844.20 in 2022[19] - The net profit attributable to shareholders for 2023 was -¥23,494,800.85, an improvement of 73.35% from -¥88,239,255.64 in the previous year[19] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥25,700,901.53, showing a 71.64% increase compared to -¥90,707,219.36 in 2022[19] - The net cash flow from operating activities for 2023 was ¥19,911,049.20, down 32.63% from ¥29,556,879.38 in the previous year[19] - The total assets at the end of 2023 were ¥891,791,823.92, a decrease of 5.47% from ¥943,629,300.31 at the end of 2022[19] - The net assets attributable to shareholders at the end of 2023 were ¥833,914,838.91, down 4.71% from ¥875,323,559.09 at the end of 2022[19] - The basic earnings per share for 2023 was -¥0.07, an improvement of 72.00% from -¥0.25 in 2022[19] - The diluted earnings per share for 2023 was also -¥0.07, reflecting the same percentage improvement as basic earnings per share[19] - The weighted average return on equity for 2023 was -2.75%, an increase of 6.76% from -9.52% in 2022[19] Market Trends - The overall scale of the maternal and infant market is expected to reach 7.75 trillion by 2024, indicating a growing market despite declining birth rates[43] - Online sales in the maternal and infant market showed growth rates of 9% and 4.9% in Q2 and Q3 2023, respectively, highlighting strong online channel performance[44] - The birth rate in China for 2023 was reported at 6.39‰, with a natural population decrease of -1.48‰, indicating demographic challenges for the industry[48] - The rise of cross-border e-commerce platforms is creating new market opportunities for maternal and infant products, particularly targeting young families[47] - The mother and baby industry is experiencing a transformation period characterized by industrial upgrades and user iteration, with domestic brands gaining market share[66] Strategic Initiatives - The company is focusing on upgrading infant products to meet rising demand for functional and specialized items, reflecting changing consumer preferences[48] - The company is adapting to a shift from growth-driven strategies to a focus on personalized consumer needs in the maternal and infant sector[48] - The company aims to explore a new model of "product + service" integration to meet the evolving consumer demands in the mother and baby sector[78] - The company is implementing a strategic shift towards online channels, leveraging new media platforms for refined operations[82] - The company is actively expanding its service layout in the medical beauty sector to enhance overall competitiveness[82] Brand and Product Development - The company has established a comprehensive product line covering all aspects of infant clothing and cotton products, demonstrating its market coverage[112] - The company has established a strong brand presence with three proprietary brands: "LABI BABY," "I LOVE BABY," and "BABY LABI," focusing on mid-to-high-end maternal and infant products[117] - The LABI BABY brand targets the mid-to-high-end maternal and infant consumer group, with a sales network covering first to fourth-tier cities and expanding into fifth and sixth-tier cities[160] - The company has been recognized as a national high-tech enterprise for the third time, highlighting its technological strength and industry recognition[78] - The company has received 24 patents, including 16 invention patents, 2 utility model patents, and 6 design patents, reflecting its strong R&D capabilities[101] Financial Management - The company reported a significant reduction in accounts payable, which decreased to CNY 15,993,102.59 from CNY 13,418,379.30, reflecting a strategic focus on cash flow management[138] - The company's cash and cash equivalents increased to CNY 223,761,868.16, up 45.7% from CNY 153,372,003.80 at the beginning of the year[137] - The company reported a significant reduction in investment losses from -¥5.64 million in 2023 compared to -¥14.22 million in 2022, showing improved investment performance[171] - The company's financial expenses included interest income of approximately ¥2.13 million in 2023, slightly down from ¥2.33 million in 2022, reflecting stable financial management[171] Consumer Behavior - The proportion of Z generation parents in the mother and baby demographic is approximately 42%, indicating a shift in consumer behavior and preferences[73] - The new generation of parents is increasingly willing to pay for high-quality and aesthetically pleasing products, indicating a shift towards a "value economy"[96] - The company acknowledges the risk of changing consumer habits, particularly among younger demographics who prefer online shopping and one-stop services[196] Operational Efficiency - The company is reforming its management model to enhance internal management efficiency, focusing on brand centers and utilizing big data analysis to understand market trends and customer needs[191] - The company is outsourcing part of its production to manufacturers that meet its technical standards, ensuring quality control throughout the process[200] - The company is enhancing employee motivation through recognition programs for outstanding store managers and shops, which has positively impacted performance[195] Future Outlook - The company plans to continue expanding its market presence and investing in new product development to drive future growth[134] - The Chinese mother and baby market is projected to benefit from supportive policies aimed at increasing birth rates, potentially leading to a new development cycle[64] - The company is investing in service-oriented business to cultivate new growth points, particularly in the medical beauty sector[197]
金发拉比(002762) - 2024 Q1 - 季度财报
2024-04-17 13:24
Financial Performance - The company's revenue for Q1 2024 was ¥43,502,464.13, a decrease of 14.86% compared to ¥51,095,758.87 in the same period last year[14] - Net profit attributable to shareholders was ¥487,509.42, down 91.01% from ¥5,423,361.79 year-on-year[14] - Basic earnings per share decreased by 95.00% to ¥0.001 from ¥0.02 in the same period last year[14] - Operating profit decreased from CNY 5,953,244.54 to CNY 1,528,951.32, a decline of 74.36%[22] - Net profit decreased from CNY 5,402,138.35 to CNY 474,072.86, a decline of 91.25%[22] - The company reported a net comprehensive income of CNY 487,509.42 for Q1 2024, down from CNY 5,423,361.79 in Q1 2023[39] Cash Flow - The net cash flow from operating activities increased by 69.17% to ¥8,884,804.34, compared to ¥5,252,145.61 in the previous year[14] - Cash received from sales of goods and services was CNY 47,907,071.16, compared to CNY 58,059,820.04 in the previous year, indicating a decline of 17.8%[39] - Operating cash inflow totaled $48,055,182.56, a decrease of 18% from $58,666,671.77[45] - Operating cash outflow amounted to $39,170,378.22, down from $53,414,526.16, resulting in a net cash flow from operating activities of $8,884,804.34, up from $5,252,145.61[45] - The net increase in cash and cash equivalents was -$142,459,038.85, contrasting with an increase of $87,394,833.28 in the previous period[45] - The ending balance of cash and cash equivalents stood at $80,750,781.58, down from $230,133,949.74[45] Assets and Liabilities - Total assets at the end of the reporting period were ¥897,875,066.34, reflecting a 0.68% increase from ¥891,791,823.92 at the end of the previous year[14] - Total liabilities rose to CNY 63,559,948.52, up from CNY 57,950,778.96, marking an increase of 9.0%[36] - The company's equity attributable to shareholders increased to CNY 834,402,348.33 from CNY 833,914,838.91, a slight increase of 0.1%[36] Expenses - The company reported a significant increase in operating expenses, with operating expenses rising to CNY 1,026,859.31 from CNY 2,853.51, an increase of 35885.83%[27] - The company’s financial expenses increased by 96.07% from CNY -2,907,409.56 to CNY -114,346.45[27] - Research and development expenses decreased from CNY 2,469,173.74 to CNY 2,214,271.33, a decline of 10.34%[22] - Other income decreased by 94.06% from CNY 278,341.03 to CNY 16,536.10[27] Investments - Cash received from investments decreased by 52.38% to ¥120,000,000.00 compared to ¥252,000,000.00 in the same period last year[18] - The company invested ¥270,000,000.00 in financial products, an increase of 58.82% from ¥170,000,000.00 in the previous year[18] - Cash paid for investments surged to $270,000,000.00 from $170,000,000.00, indicating a significant increase in investment activity[45] Shareholder Information - Total number of common shareholders at the end of the reporting period is 44,900[19] - The largest shareholder, Lin Haoliang, holds 27.29% of shares, totaling 96,628,899 shares[19] Taxation - The company reported a significant decrease in tax payments, down 56.58% to ¥3,853,720.54 from ¥8,875,023.80 in the previous year[18] - Tax payments decreased to ¥3,853,720.54 from ¥8,875,023.80, indicating a potential change in tax obligations or strategies[45] Future Plans - The company plans to expand its market presence and invest in new product development[23] - The company has not disclosed any new product launches or significant market expansion strategies during this quarter[39]